{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:39:19Z","timestamp":1770568759091,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.jpainsymman.2007.05.011","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T09:13:05Z","timestamp":1202289185000},"page":"420-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study"],"prefix":"10.1016","volume":"35","author":[{"given":"Neil A.","family":"Hagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"du Souich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Lapointe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Ong-Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Walde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh Ho","family":"Ngoc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2007.05.011_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","author":"Mantyh","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib2","first-page":"985","article-title":"Pain intensity and pain interference in hospitalized patients with cancer","volume":"27","author":"Wells","year":"2000","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jpain.2006.02.007","article-title":"Risk factors for chronic pain following breast cancer surgery: a prospective study","volume":"7","author":"Poleshuck","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0885-3924(95)90924-C","article-title":"Opioid rotation for toxicity reduction in terminal cancer patients","volume":"10","author":"de Stoutz","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib6","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00002820-200507000-00014","article-title":"Pain and desire for hastened death in terminally ill cancer patients","volume":"28","author":"Mystakidou","year":"2005","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpainsymman.2004.08.010","article-title":"Desire for hastened death, cancer pain and depression: report of a longitudinal observational study","volume":"29","author":"O'Mahony","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00001786-200507000-00012","article-title":"Developing a pain management program through continuous improvement strategies","volume":"20","author":"Woodward","year":"2005","journal-title":"J Nurs Care Qual"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1634\/theoncologist.11-7-765","article-title":"Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients","volume":"11","author":"Ross","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(97)00012-2","article-title":"Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons","volume":"72","author":"Omana-Zapata","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(00)02451-3","article-title":"Low dose of tetrodotoxin reduces neuropathic pain behaviors in an animal model","volume":"871","author":"Lyu","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/bja\/ael096","article-title":"Antinociceptive effects of tetrodotoxin (TTX) in rodents","volume":"96","author":"Marcil","year":"2006","journal-title":"Br\u00a0J Anaesth"},{"issue":"5 Suppl 3","key":"10.1016\/j.jpainsymman.2007.05.011_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jpain.2006.01.444","article-title":"The role of sodium channels in chronic inflammatory and neuropathic pain","volume":"7","author":"Amir","year":"2006","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.jpainsymman.2007.05.011_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpainsymman.2006.11.008","article-title":"An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain","volume":"34","author":"Hagen","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/WNL.48.2.332","article-title":"Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale","volume":"48","author":"Galer","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib17","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00000542-199510000-00017","article-title":"Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats","volume":"83","author":"Chaplan","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3959(02)00350-0","article-title":"Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions","volume":"103","author":"Araujo","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0885-3924(06)80004-7","article-title":"A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain","volume":"7","author":"Bruera","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib23","article-title":"Systemic administration of local anesthetic agents to relieve neuropathic pain","volume":"4","author":"Challapalli","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(96)09024-1","article-title":"Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain","volume":"349","author":"Dellemijn","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib26","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib27","first-page":"A59","article-title":"Tetrodotoxin (TTX) in the management of pain in animals and humans with cancer (Abstract)","volume":"44","author":"du Souich","year":"2002","journal-title":"Pharmacologist"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib28","first-page":"16","article-title":"Comparison of adverse drug effects (ADEs) of tetrodotoxin (TTX) in healthy volunteers with the analgesic effect in patients (Abstract)","volume":"71","author":"du Souich","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib29","first-page":"16","article-title":"Pharmacologic effects and safety of single and multiple doses of tetrodotoxin (TTX) (Abstract)","volume":"71","author":"Sellers","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib30","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.284.22.2907","article-title":"Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer","volume":"284","author":"Breitbart","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib31","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1176\/ajp.152.8.1185","article-title":"Desire for death in the terminally ill","volume":"152","author":"Chochinov","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib33","article-title":"Gabapentin for acute and chronic pain","volume":"3","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1089\/jpm.2005.8.1118","article-title":"Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study","volume":"8","author":"Ross","year":"2005","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2007.05.011_bib35","article-title":"Carbamazepine for acute and chronic pain","volume":"3","author":"Wiffen","year":"2005","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407007440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407007440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:59:37Z","timestamp":1760129977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392407007440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0885392407007440"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.05.011","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}